Literature DB >> 16772856

Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness.

Julie Kreyenbuhl1, Faith B Dickerson, Deborah R Medoff, Clayton H Brown, Richard W Goldberg, Lijuan Fang, Karen Wohlheiter, Leena P Mittal, Lisa B Dixon.   

Abstract

Cardiovascular disease is the leading cause of death in Type 2 diabetes, which commonly occurs in patients with serious mental illnesses (SMIs). We determined the extent to which patients with diabetes and SMI, relative to diabetes patients without SMI, met American Diabetes Association goals for cholesterol and blood pressure, met criteria for the metabolic syndrome, and were prescribed medications known to reduce cardiovascular events. We found that less than half of diabetes patients, both with and without SMI, met recommended goals for cholesterol levels; even fewer had adequate blood pressure control. In addition, a substantial proportion of all diabetes patients met metabolic syndrome criteria. However, diabetes patients with SMI were less likely to be prescribed cholesterol-lowering statin medications, angiotensin-converting enzyme inhibitors, and angiotensin receptor blocking agents than diabetes patients without SMI. Patients with both diabetes and SMI are treated less aggressively for high cardiovascular risk than diabetes patients without mental disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772856      PMCID: PMC3673558          DOI: 10.1097/01.nmd.0000221177.51089.7d

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  42 in total

Review 1.  The evolving diabetes burden in the United States.

Authors:  Michael M Engelgau; Linda S Geiss; Jinan B Saaddine; James P Boyle; Stephanie M Benjamin; Edward W Gregg; Edward F Tierney; Nilka Rios-Burrows; Ali H Mokdad; Earl S Ford; Giuseppina Imperatore; K M Venkat Narayan
Journal:  Ann Intern Med       Date:  2004-06-01       Impact factor: 25.391

2.  Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.

Authors:  Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

3.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

Review 4.  Cardiovascular outcomes among participants with diabetes in the recent large statin trials.

Authors:  Jane Armitage; Louise Bowman
Journal:  Curr Opin Lipidol       Date:  2004-08       Impact factor: 4.776

Review 5.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

6.  A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses.

Authors:  Lisa B Dixon; Julie A Kreyenbuhl; Faith B Dickerson; Thomas W Donner; Clayton H Brown; Karen Wohlheiter; Karen Wolheiter; Leticia Postrado; Richard W Goldberg; LiJuan Fang; Christopher Marano; Erick Messias
Journal:  Psychiatr Serv       Date:  2004-08       Impact factor: 3.084

7.  Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study.

Authors:  Eve A Kerr; Robert B Gerzoff; Sarah L Krein; Joseph V Selby; John D Piette; J David Curb; William H Herman; David G Marrero; K M Venkat Narayan; Monika M Safford; Theodore Thompson; Carol M Mangione
Journal:  Ann Intern Med       Date:  2004-08-17       Impact factor: 25.391

8.  The intensification of drug therapy for diabetes and its complications: evidence from 2 HMOs.

Authors:  David P Nau; Mathew C Garber; William H Herman
Journal:  Am J Manag Care       Date:  2004-02       Impact factor: 2.229

9.  Evaluation of angiotensin-converting enzyme inhibitor use in patients with type 2 diabetes in a state managed care plan.

Authors:  Erin M Timpe; Naseem Amarshi; Pamala J Reed
Journal:  Am J Manag Care       Date:  2004-02       Impact factor: 2.229

10.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.

Authors:  Sharon H Saydah; Judith Fradkin; Catherine C Cowie
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

View more
  37 in total

1.  Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder.

Authors:  Jess G Fiedorowicz; David A Solomon; Jean Endicott; Andrew C Leon; Chunshan Li; John P Rice; William H Coryell
Journal:  Psychosom Med       Date:  2009-06-26       Impact factor: 4.312

Review 2.  Cardiovascular morbidity and mortality in bipolar disorder.

Authors:  Miriam Weiner; Lois Warren; Jess G Fiedorowicz
Journal:  Ann Clin Psychiatry       Date:  2011-02       Impact factor: 1.567

3.  Comorbid Diabetes and Severe Mental Illness: Outcomes in an Integrated Health Care Delivery System.

Authors:  Christina Mangurian; Dean Schillinger; John W Newcomer; Eric Vittinghoff; Susan Essock; Zheng Zhu; Wendy Dyer; Kelly C Young-Wolff; Julie Schmittdiel
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

4.  Primary care physician perceptions on caring for complex patients with medical and mental illness.

Authors:  Danielle F Loeb; Elizabeth A Bayliss; Ingrid A Binswanger; Carey Candrian; Frank V deGruy
Journal:  J Gen Intern Med       Date:  2012-02-28       Impact factor: 5.128

5.  Quality of care for heart failure among disabled Medicaid recipients with and without severe mental illness.

Authors:  Saul Blecker; Yiyi Zhang; Daniel E Ford; Eliseo Guallar; Susan Dosreis; Donald M Steinwachs; Lisa B Dixon; Gail L Daumit
Journal:  Gen Hosp Psychiatry       Date:  2010-03-16       Impact factor: 3.238

6.  Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans.

Authors:  Lydia A Chwastiak; Robert A Rosenheck; Lewis E Kazis
Journal:  Psychosomatics       Date:  2011 May-Jun       Impact factor: 2.386

7.  Does a Physician's Attitude toward a Patient with Mental Illness Affect Clinical Management of Diabetes? Results from a Mixed-Method Study.

Authors:  Lisa C Welch; Heather J Litman; Christina P C Borba; Brenda Vincenzi; David C Henderson
Journal:  Health Serv Res       Date:  2014-12-09       Impact factor: 3.402

Review 8.  Mania and mortality: why the excess cardiovascular risk in bipolar disorder?

Authors:  Dylan P Murray; Miriam Weiner; Maithri Prabhakar; Jess G Fiedorowicz
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

9.  Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization.

Authors:  Laurel A Copeland; John E Zeber; Chen-Pin Wang; Michael L Parchman; Valerie A Lawrence; Marcia Valenstein; Alexander L Miller
Journal:  BMC Health Serv Res       Date:  2009-07-26       Impact factor: 2.655

10.  Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetes.

Authors:  Julie Kreyenbuhl; Deborah R Medoff; Stephen L Seliger; Lisa B Dixon
Journal:  Schizophr Res       Date:  2008-03-19       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.